Autopsy report · NCT00003520

Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“slow accrual”

The sponsor’s own words in the registry.

Life of this trial

Registered 3 years 7 months after it had already started.
Ran for about 8 years 10 months before it stopped.
15 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Burzynski Research Institute
Sponsor type: University, hospital or other
Conditions: Stage IV Kidney Cancer
Interventions: Antineoplaston therapy (Atengenal + Astugenal)
Participants: 15
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.